🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Postprandial glucose (PPG) excursions are not only determined by insulin-me...
Status
Completed
Location
Multiple Locations
Start Date
2015-08
Trial ID
NCT02640118
Treatments Being Tested
Impact of combined Lantus (insulin glargine) and Lyxumia(lixisenatide) on i...
Status
Completed
Location
St. Josef-Hospital, University Hospital, Ruhr
Start Date
2013-12
Trial ID
NCT01910194
Treatments Being Tested
Incretinomimetics and inhibitors of dipeptidyl peptidase-4 (DPP-4) are new ...
Status
Terminated
Location
Gastroenterology Department Erasme Hospital
Start Date
2014-10
Trial ID
NCT02244164
Treatments Being Tested
The current study has two aims: 1. to test the hypothesis that a single do...
Status
Unknown
Location
Tartu University Hospital
Start Date
2023-04-17
Trial ID
NCT05804513
Treatments Being Tested
The purpose of this study is to evaluate the benefits and risks of lixisena...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2008-05
Trial ID
NCT00688701
Treatments Being Tested
Primary Objective: * to assess the relative bioavailability of a single do...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2010-06
Trial ID
NCT01146678
Treatments Being Tested
Primary Objective: * To demonstrate the superiority of Soliqua 100/33 vers...
Status
Terminated
Location
Investigational Site Number 8400072
Start Date
2018-02-20
Trial ID
NCT03434119
Treatments Being Tested
Primary Objective: To compare the insulin glargine/lixisenatide fixed rati...
Status
Completed
Location
Investigational Site Number 840027
Start Date
2014-02
Trial ID
NCT02058147
Primary Objective: To demonstrate significant reduction in postprandial pl...
Status
Completed
Location
Investigational Site Number 392-107
Start Date
2014-08
Trial ID
NCT02200991
Treatments Being Tested
Primary Objective: To evaluate the ability of lixisenatide to modulate pos...
Status
Terminated
Location
Multiple Locations
Start Date
2015-04
Trial ID
NCT02274740
Treatments Being Tested